{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:07:17Z","timestamp":1793452037026,"version":"4.5.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Reprod Sci"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0974-1208.121400","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T11:00:04Z","timestamp":1384426804000},"page":"168","source":"Crossref","is-referenced-by-count":171,"title":["Hyperprolactinemia"],"prefix":"10.4103","volume":"6","author":[{"given":"Abha","family":"Majumdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NishaSharma","family":"Mangal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-1208.121400-1","first-page":"1075","volume-title":"Guidelines for the diagnosis and treatment of hyperprolactinemia","author":"Biller","year":"1999","journal-title":"J Reprod Med"},{"key":"key-10.4103\/0974-1208.121400-2","doi-asserted-by":"crossref","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: Structure, function, and regulation of secretion. Physiol Rev 2000;80:1523-631.","DOI":"10.1152\/physrev.2000.80.4.1523"},{"key":"key-10.4103\/0974-1208.121400-3","first-page":"3927","volume-title":"The impact on clinical practice of routine screening for macroprolactin","author":"Gibney","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-4","first-page":"552","volume-title":"Patients with macroprolactinaemia: Clinical and radiological features","author":"Donadio","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"key-10.4103\/0974-1208.121400-5","first-page":"466","volume-title":"Should macroprolactin be measured in all hyperprolactinaemic sera?","author":"McKenna","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/0974-1208.121400-6","first-page":"141","volume-title":"Hyperprolactinemia","author":"Chahal","year":"2008","journal-title":"Pituitary"},{"key":"key-10.4103\/0974-1208.121400-7","first-page":"1048","volume-title":"Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay","author":"Glezer","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-8","first-page":"1157","volume-title":"Control of prolactin secretion","author":"Benker","year":"1990","journal-title":"Klin Wochenschr"},{"key":"key-10.4103\/0974-1208.121400-9","first-page":"53","volume-title":"Elevated prolactin levels in patients with schizophrenia: Mechanisms and related adverse effects","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinol"},{"key":"key-10.4103\/0974-1208.121400-10","first-page":"747","volume-title":"Prolactin suppresses malonyl-CoA concentration in human adipose tissue","author":"Nilsson","year":"2009","journal-title":"Horm Metab Res"},{"key":"key-10.4103\/0974-1208.121400-11","unstructured":"Huang I, Gibson M, Peterson CM. Endocrine disorders. In: Berek JS. editor. Berek and Novak\u2032s Gynecology, 14 th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 1069-136."},{"key":"key-10.4103\/0974-1208.121400-12","unstructured":"Webster J, Scanlon MF. Prolactinomas. In: Sheaves R, Jenkins PJ, Wass JA, editors. Clinical Endocrine Oncology. Oxford: Blackwell Science; 1997. p. 189-94."},{"key":"key-10.4103\/0974-1208.121400-13","first-page":"220","volume-title":"Dopamine agonists and pituitary tumor shrinkage","author":"Bevan","year":"1992","journal-title":"Endocr Rev"},{"key":"key-10.4103\/0974-1208.121400-14","first-page":"589","volume-title":"Galactorrhea: A study of 235 cases, including 48 with pituitary tumors","author":"Kleinberg","year":"1977","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-1208.121400-15","first-page":"91","volume-title":"Prolactin secretion in sixty-five patients with galactorrhea","author":"Tolis","year":"1974","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/0974-1208.121400-16","first-page":"165","volume-title":"Galactorrhea-amenorrhea syndrome: Diagnosis and therapy","author":"Boyd","year":"1977","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0974-1208.121400-17","first-page":"303","volume-title":"Prolactin release inpolycystic ovarian syndrome","author":"Minakami","year":"1988","journal-title":"Endocrinol Jpn"},{"key":"key-10.4103\/0974-1208.121400-18","first-page":"1511","volume-title":"Decreased bone density in hyperprolactinemic women","author":"Klibanski","year":"1980","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-1208.121400-19","first-page":"1021","volume-title":"Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea","author":"Schlechte","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-20","first-page":"692","volume-title":"Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea","author":"Biller","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-21","first-page":"124","volume-title":"Effects of prolactin and estrogen deficiency in amenorrheic bone loss","author":"Klibanski","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-22","first-page":"74","volume-title":"Hyperprolactinemia","author":"Biller","year":"1999","journal-title":"Int J Fertil Womens Med"},{"key":"key-10.4103\/0974-1208.121400-23","first-page":"1085","volume-title":"Clinical presentation of hyperprolactinemia","author":"Luciano","year":"1999","journal-title":"J Reprod Med"},{"key":"key-10.4103\/0974-1208.121400-24","unstructured":"Melmed S, Jameson JL. Disorders of the anterior pituitary and hypothalamus. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison\u2032s Principles of Internal Medicine, 16 th ed. New York: McGraw Hill; 2008. p. 2076-97."},{"key":"key-10.4103\/0974-1208.121400-25","first-page":"502","volume-title":"Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma","author":"Erem","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/0974-1208.121400-26","first-page":"425","volume-title":"Risperidone-associated hyperprolactinemia","author":"Kearns","year":"2000","journal-title":"Endocr Pract"},{"key":"key-10.4103\/0974-1208.121400-27","first-page":"273","volume-title":"Endocrine Society.Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-28","first-page":"2861","volume-title":"Long-term management of prolactinomas","author":"Schlechte","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-29","first-page":"1101","volume-title":"Psychotic reactions during treatment of pituitary tumours with dopamine agonists","author":"Turner","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key-10.4103\/0974-1208.121400-30","first-page":"670","volume-title":"A comparison of bromocriptine and cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination","author":"Motazedian","year":"2010","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/0974-1208.121400-31","first-page":"505","volume-title":"Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET","author":"Bahceci","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"key-10.4103\/0974-1208.121400-32","first-page":"656","volume-title":"Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists","author":"Horvath","year":"2004","journal-title":"Mov Disord"},{"key":"key-10.4103\/0974-1208.121400-33","first-page":"611","volume-title":"New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance","author":"Rascol","year":"2004","journal-title":"Mov Disord"},{"key":"key-10.4103\/0974-1208.121400-34","first-page":"78","volume-title":"Drugs five years later.Bromocriptine","author":"Vance","year":"1984","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0974-1208.121400-35","first-page":"882","volume-title":"Increased circulating levels of bromocriptine after vaginal compared with oral administration","author":"Katz","year":"1991","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.121400-36","first-page":"267","volume-title":"Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: Comparison of their prolactin lowering activity, tolerability and safety","author":"Merola","year":"1991","journal-title":"Gynecol Endocrinol"},{"key":"key-10.4103\/0974-1208.121400-37","first-page":"74","volume-title":"A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: A multicenter study","author":"Brue","year":"1992","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.121400-38","first-page":"3578","volume-title":"Long-term follow-up of prolactinomas: Normoprolactinemia after bromocriptine withdrawal","author":"Passos","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-39","first-page":"5256","volume-title":"Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: Prevalence, clinical definition, and therapeutic strategy","author":"Di","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-40","first-page":"440","volume-title":"Vaginal cabergoline in the treatment of hyperprolactinemic patients intolerant to oral dopaminergics","author":"Motta","year":"1996","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.121400-41","first-page":"E1228","volume-title":"Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men","author":"George","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-42","first-page":"485","volume-title":"Advances in the treatment of prolactinomas","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"key-10.4103\/0974-1208.121400-43","first-page":"265","volume-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/0974-1208.121400-44","first-page":"524","volume-title":"Efficacy and safety of bromocriptine in the treatment of macroprolactinomas","author":"Essa\u00efs","year":"2002","journal-title":"Ann Endocrinol (Paris)"},{"key":"key-10.4103\/0974-1208.121400-45","first-page":"1427","volume-title":"Clonal origin of pituitary adenomas","author":"Herman","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.121400-46","first-page":"399","volume-title":"Megavoltage pituitary irradiation in the management of prolactinomas: Long-term follow-up","author":"Tsagarakis","year":"1991","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:18:39Z","timestamp":1786648719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-1208.121400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"alternative-id":["121400"],"URL":"https:\/\/doi.org\/10.4103\/0974-1208.121400","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}